A large number of studies have shown that the topical application of TRPV3 inhibitors can effectively inhibit skin pruritus and pain, which provides a new idea for the treatment of intractable pruritus and pain diseases such as Olmsted syndrome and hereditary palmoplantar keratosis. This evidence concerns the gene TRPV3 and Olmsted syndrome.